Takeshi Matsugi

Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug

Yasutaka Takagi, Tadashi Nakajima, Atsushi Shimazaki et al. · Experimental Eye Research · 2004 · 146 citations

Pharmacological Characteristics, Ocular Hypotensive Drug, Ocular Disease +6

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

Tomoko Kirihara, Takazumi Taniguchi, Kenzo Yamamura et al. · Investigative Ophthalmology & Visual Science · 2018 · 92 citations · Full text

Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys

Masahiro Fuwa, Carol B. Toris, Shan Fan et al. · Journal of Ocular Pharmacology and Therapeutics · 2018 · 90 citations · Full text

New Fluoroprostaglandin F2.ALPHA. Derivatives with Prostanoid FP-Receptor Agonistic Activity as Potent Ocular-Hypotensive Agents

Tadashi Nakajima, Takeshi Matsugi, Wakana Goto et al. · Biological and Pharmaceutical Bulletin · 2003 · 83 citations · Full text

Adenosine-induced relaxation of cultured bovine retinal pericytes.

Takeshi Matsugi, Qian Chen, Douglas R. Anderson · PubMed · 1997 · 71 citations